Abstract
BRAIN-derived neurotrophic factor (BDNF), present in minute amounts in the adult central nervous system1, is a member of the nerve growth factor (NGF) (ref. 2) family, which includes neurotrophin-3 (NT-3) (refs 3–5). NGF, BDNF and NT-3 all support survival of subpopulations of neural crest-derived sensory neurons3–5; most sympathetic neurons are responsive to NGF (ref. 2), but not to BDNF1,6,7; NT-3 and BDNF, but not NGF (ref. 6), promote survival of sensory neurons of the nodose ganglion3–8. BDNF, but not NGF, supports the survival of cultured retinal ganglion cells9 but both NGF and BDNF promote the survival of septal cholinergic neurons in vitro10,11. However, knowledge of their precise physiological role in development and maintenance of the nervous system neurons is still limited. The BDNF gene is expressed in many regions of the adult CNS12‐14, including the striatum12. A protein partially purified from bovine striatum, a target of nigral dopaminergic neurons, with characteristics apparently similar to those of BDNF, can enhance the survival of dopaminergic neurons in mesencephalic cultures15. BDNF seems to be a trophic factor for mesencephalic dopaminergic neurons, increasing their survival, including that of neuronal cells which degenerate in Parkinson's disease. Here we report the effects of BDNF on the survival of dopaminergic neurons of the developing substantia nigra.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Barde, Y.-A., Edgar, D. & Thoenen, H. EMBO J 1, 549–553 (1982).
Levi-Montalcini, R. & Angeletti, P. U. Physiol. Rev. 48, 534–569 (1968).
Hohn, A., Leibrock, J., Bailey, K. & Barde, Y.-A. Nature 344, 339–341 (1990).
Maisonpierre, P. C. et al. Science 247, 1446–1451 (1990).
Rosenthal, A. et al. Neuron 4, 767–773 (1990).
Lindsay, R. M., Thoenen, H. & Barde, Y.-A. Devl Biol. 112, 318–328 (1985).
Davies, A. M., Thoenen, H. & Barde, Y.-A. J. Neurosci. 6, 1897–1904 (1986).
Hofer, M. M. & Barde, Y.-A. Nature 331, 261–262 (1988).
Johnson, J. E., Barde, Y.-A., Schwab, M. & Thoenen, H. J. Neurosci. 6, 3031–3038 (1986).
Hartikka, J. & Hefti, F. J. Neurosci. 8, 2967–2985 (1988).
Alderson, R. F., Alterman, A. L., Barde, Y.-A. & Lindsay, R. M. Neuron 5, 297–306 (1990).
Hofer, M., Pagliusi, S. R., John, A., Leibrock, J. & Barde, Y.-A. EMBO J. 9, 2459–2464 (1990).
Maisonpierre, P. C. et al. Neuron 5, 501–509 (1990).
Phillips, H. S., Hains, J. M., Laramee, G. R., Rosenthal, A. & Winslow, J. W. Science 250, 290–294 (1990).
Dal Toso, R. et al. J. Neurosci. 8, 733–745 (1988).
Bignami, A., Eng, L. F., Dahl, D. & Uyeda, C. T. Brain Res. 43, 429–435 (1972).
Knusel, B., Michel, P. P., Schwaber, S. & Hefti, F. J. Neurosci. 10, 558–570 (1990).
Rodriguez-Tébar, A., Dechant, G. & Barde, Y.-A. Neuron 4, 487–492 (1990).
Chandler, C. E., Parson, L. M., Hosang, M. & Shooter, E. M. J. biol. Chem. 259, 6882–6889 (1984).
Zigmond, M. J. & Stricker, E. M. Int. Rev. Neurobiol. 31, 1–79 (1989).
Sanchez-Ramos, J. R., Barrett, J. N., Goldstein, M., Weiner, W. & Hefti, F. Neurosci. Lett. 72, 215–220 (1986).
Sanchez-Ramos, J., Michel, P., Weiner, W. J. & Hefti, F. J. Neurochem. 50, 1934–1944 (1988).
Michel, P. P., Dandapani, B. K., Knusel, B., Sanchez-Ramos, J. & Hefti, F. J. Neurochem. 54, 1102–1109 (1990).
Prochiantz, A., DiPorzio, U., Kato, A., Berger, B. & Glowinski, J. Proc. natn. Acad. Sci. U.S.A. 76, 5387–5391 (1979).
DiPorzio, U., Daguet, M.-C., Glowinski, J. & Prochiantz, A. Nature 288, 370–373 (1980).
Prochiantz, A., Daguet, M.-C., Herbert, A. & Glowinski, J. Nature 293, 570–572 (1981).
Denis-Donini, S., Glowinski, J. & Prochiantz, A. J. Neurosci. 3, 2292–2299 (1983).
Ferrari, G., Minozzi, M. C., Toffano, G., Leon, A. & Skaper, S. D. Devl Biol. 133, 140–147 (1989).
Otto, D. & Unsicker, K. J. Neurosci. 10, 1912–1921 (1990).
Langston, J. W., Ballard, P., Tetrud, J. W. & Irwin, I. Science 219, 979–980 (1983).
Langston, J. W., Forno, L. S., Rebert, C. S. & Irwin, I. Brain Res. 292, 390–394 (1984).
Bottenstein, J. E. & Sato, G. H. Proc. natn. Acad. Sci. U.S.A. 76, 514–517 (1979).
Wray, W., Boulikas, T., Wrax, V. P. & Hancock, R. Analyt. Biochem. 118, 197–203 (1981).
Yancopoulos, G. D. et al. Cold Spring Harb. Symp. quant. Biol. (in the press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hyman, C., Hofer, M., Barde, YA. et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350, 230–232 (1991). https://doi.org/10.1038/350230a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/350230a0
This article is cited by
-
Brain-derived neurotrophic factor serum levels as a candidate biomarker for withdrawal in crack heroin dependence
Substance Abuse Treatment, Prevention, and Policy (2024)
-
Sericin alleviates motor dysfunction by modulating inflammation and TrkB/BDNF signaling pathway in the rotenone-induced Parkinson’s disease model
BMC Pharmacology and Toxicology (2023)
-
Delayed Outgrowth in Response to the BDNF and Altered Synaptic Proteins in Neurons From SHR Rats
Neurochemical Research (2023)
-
Reinstatement of nicotine conditioned place preference in a transgenerational model of drug abuse vulnerability in psychosis: Impact of BDNF on the saliency of drug associations
Psychopharmacology (2023)
-
A case of early-onset Parkinson’s disease in a patient with KBG syndrome
Neurological Sciences (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.